About the Conference:
The successful biannual ESH Conferences on Acute Myeloid Leukemia (AML) have established themselves as scientific and educational programs at the interphase of molecular and biologic developments and clinical translation. Novel technological, molecular and immunologic approaches are rapidly creating novel insights into the biology and therapeutic perspectives of AML.
This educational conference has been approved for 18 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH).
Read more...
With the support of*:
Diamond Conference Partner
*******
Emerald Conference Partners
*******
Ruby Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.